For instance, the expression level of CD44, which may interact with Eno1 and MSN, can be expressed higher in cancer cells than noncancer cells, and thus the impact of CD44-mediated cytotoxicity is stronger in tumor cells. This evidence concerns the gene ENO1 and cancer.